A reference point for advanced pharmacovigilance models
The
European Pharmacovigilance Congress 2025
, organised by
Pharma Education Center
, is recognised as one of the key international forums for
drug safety
and
pharmacovigilance operations
, bringing together authorities, QPPVs, industry leaders and experts to discuss scientific, regulatory and organisational priorities for the years ahead.
Within this context,
ProductLife Group
does not simply attend as a participant. The Group contributes as a
content leader
, helping to shape the conversation on how safety systems evolve in a world where new data sources, AI and global frameworks are redefining expectations.
Human AI collaboration in the spotlight
Among PLG's contributions, particular attention goes to the intervention of
Gabrièle Piaton-Breda
,
Research & Innovation Director at PLG
, who focuses on
Human AI collaboration in pharmacovigilance
. Her session explores how human oversight and intelligent technologies can interact in a structured way, so that AI supports, rather than replaces, expert judgement.
Key themes include the role of AI in
signal detection
, the impact on
risk assessment and decision support
, and the importance of clear
governance models
that define responsibilities, validation, monitoring and escalation. The aim is to move beyond generic discussions on automation and address what it truly means to build PV systems that are
AI-enabled, transparent and inspection-ready
.
From congress themes to PLG capabilities
The topics at the
European Pharmacovigilance Congress
reflect issues that PLG teams encounter daily: the integration of
real-world data
into safety evaluation, the alignment of
global PV frameworks
, the management of
audits and inspections
, and the introduction of digital tools without compromising control.
Through its global network,
ProductLife Group
supports organisations in translating these priorities into practical solutions. This includes the design and optimisation of
PV systems and QMS
, support for
GVP compliance
and
inspection readiness
, optimisation of
signal management
processes, and strategic guidance on
AI and data governance
within safety operations. The focus is always on building structures that are
robust, scalable and proportionate
to each company's portfolio, markets and risk profile.
Why choose PLG for Pharmacovigilance
For companies that want to strengthen or transform their
pharmacovigilance
set-up, PLG offers a combination of
scientific expertise, regulatory insight
and
operational experience
across regions. The Group provides support along the entire PV lifecycle, from early system design and global process harmonisation to vendor oversight, technology enablement and post-inspection remediation.
Participation in events such as the
European Pharmacovigilance Congress 2025
reinforces this role. By contributing to the scientific dialogue and sharing concrete experience from real projects,
ProductLife Group
helps organisations move towards safety models that protect patients, satisfy regulators and support long-term business strategy.
If you are interested or would like to explore further, contact us
Contact us